HIGHLIGHTS
- who: Xuchen Huang and collaborators from the Yat-sen, China have published the research work: Efficacy and safety of apatinib monotherapy for patients with advanced breast cancer: a systematic review and meta-analysis, in the Journal: (JOURNAL) of 21/03/2022
- what: The authors design this systematic review and meta-analysis to collect and pool efficacy and safety data of apatinib monotherapy for ABC and present the following article in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting checklist. Although two retrospective studies were designed to evaluate the efficacy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.